Matinas BioPharma Holdings (MTNB) Curent Deferred Tax Liability (2015)
Matinas BioPharma Holdings (MTNB) reported Curent Deferred Tax Liability of $1.3 million for Q2 2015, little changed quarter-over-quarter from $1.3 million in Q1 2015.
Matinas BioPharma Holdings (MTNB) Curent Deferred Tax Liability (2015) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has 1 years of Curent Deferred Tax Liability data on file, last reported at $1.3 million in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 1.25 Mn |
| Jun 30, 2015 | 1.25 Mn |
| Mar 31, 2015 | 1.25 Mn |
| Mar 31, 2015 | 1.25 Mn |